Guggenheim Securities Initiates Coverage on Zimmer Biomet Holdings Inc(NYSE:ZBH). The shares have been rated Neutral. The rating by Guggenheim Securities was issued on Jun 9, 2016.
In a different note, On May 25, 2016, Argus Research said it Upgrades its rating on Zimmer Biomet Holdings Inc. The shares have been rated ‘Buy’ by the firm. On May 25, 2016, Argus Research said it Upgrades its rating on Zimmer Biomet Holdings Inc. The shares have been rated ‘Buy’ by the firm. On May 2, 2016, Leerink Swann said it Maintains its rating on Zimmer Biomet Holdings Inc. In the research note, the firm Raises the price-target to $124.00 per share. The shares have been rated ‘Outperform’ by the firm. Nomura said it Initiates Coverage on Zimmer Biomet Holdings Inc, according to a research note issued on Mar 17, 2016. The shares have been rated ‘Buy’ by the firm.
Zimmer Biomet Holdings Inc (ZBH) shares turned negative on Wednesdays trading session with the shares closing down -0.4 points or -0.34% at a volume of 18,42,203. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $117.15. The peak price level was also seen at $117.15 while the days lowest was $116.13. Finally the shares closed at $116.42. The 52-week high of the shares is $123.43 while the 52-week low is $88.27. According to the latest information available, the market cap of the company is $23,195 M.
Zimmer Biomet Holdings Inc has also declared a cash dividend of $0.2400 on May 23, 2016. The shares will quote ex-dividend on Jun 22, 2016 and the record date has been fixed on Jun 24, 2016. The dividend payable date has been fixed on Jul 29, 2016.
Zimmer Biomet Holdings Inc(ZBH) last announced its earnings results on Apr 28, 2016 for Fiscal Year 2016 and Q1.Company reported revenue of $1.90B. Analysts had an estimated revenue of $1.88B. Earnings per share were $2.00. Analysts had estimated an EPS of $1.93.
Several Insider Transactions has been reported to the SEC. On Apr 18, 2016, Daniel P Florin (Sr. VP, CFO) sold 10,000 shares at $114.98 per share price.Also, On Mar 22, 2016, David C Dvorak (President and CEO) sold 1,540 shares at $104.16 per share price.On Dec 3, 2015, David A. Jr. Nolan (Group President) sold 3,435 shares at $102.62 per share price, according to the Form-4 filing with the securities and exchange commission.
Zimmer Biomet Holdings Inc. formerly Zimmer Holdings Inc. is a musculoskeletal healthcare company. The Company designs manufactures and markets orthopedic reconstructive products; sports medicine biologics extremities and trauma products; spine bone healing craniomaxillofacial and thoracic products; dental implants and related surgical products. The Company manages its operations through three geographic segments: the Americas comprising principally of the United States and includes other North Central and South American markets; Europe comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers and directly to dental practices and dental laboratories.